Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
10.42
+0.01 (0.10%)
At close: May 12, 2025, 4:00 PM
10.49
+0.07 (0.67%)
After-hours: May 12, 2025, 6:16 PM EDT
Amarin Corporation Employees
Amarin Corporation had 275 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
275
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$778,589
Profits / Employee
-$319,735
Market Cap
215.79M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AMRN News
- 5 days ago - Amarin Corporation plc (AMRN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 14 days ago - Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 - GlobeNewsWire
- 4 weeks ago - Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday - Benzinga
- 4 weeks ago - Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change - GlobeNewsWire
- 5 weeks ago - Amarin Appoints JEC Capital Partners' Michael Torok to Board of Directors - GlobeNewsWire
- 7 weeks ago - Concerned Shareholder Group Urges Amarin's Board of Directors to Initiate a Strategic Review Following Two Years of Underperformance - Business Wire
- 7 weeks ago - New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo - GlobeNewsWire